These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37876921)

  • 1. Pharmacovigilance and Adverse Drug Reactions Reporting: Healthcare Providers' Experiences from Southern Highland Tanzania.
    Mwakawanga DL; Kilonzi M; Philipo EG; Martine A; Mbilinyi T; Kileo NF; Mkinga B; Shonyella CJ; Mohamedi JA; Clement A; Mwasomola D; Mushy SE; Sirili N
    Adv Pharmacol Pharm Sci; 2023; 2023():5537592. PubMed ID: 37876921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-care Professionals' Knowledge and Perception of Adverse Drug Reaction Reporting and Pharmacovigilance in a Tertiary Care Teaching Hospital of Nepal.
    Danekhu K; Shrestha S; Aryal S; Shankar PR
    Hosp Pharm; 2021 Jun; 56(3):178-186. PubMed ID: 34024926
    [No Abstract]   [Full Text] [Related]  

  • 3. Awareness, knowledge, and attitude toward adverse drug reaction (ADR) reporting among healthcare professionals in Ghana.
    Yawson AA; Abekah-Nkrumah G; Okai GA; Ofori CG
    Ther Adv Drug Saf; 2022; 13():20420986221116468. PubMed ID: 35966898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring healthcare professionals' knowledge, attitude, and practices towards pharmacovigilance: a cross-sectional survey.
    Hussain R; Hassali MA; Hashmi F; Akram T
    J Pharm Policy Pract; 2021 Jan; 14(1):5. PubMed ID: 33397478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knowledge, attitudes and perspective on adverse drug reaction reporting in a public sector hospital in South Africa: baseline analysis.
    Terblanche A; Meyer JC; Godman B; Summers RS
    Hosp Pract (1995); 2017 Dec; 45(5):238-245. PubMed ID: 28914115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knowledge, attitudes and practice regarding pharmacovigilance and adverse drug reaction reporting among physicians and pharmacists in Egypt: a step toward personalized medicine implementation.
    Aziz AA; Rogers S; Hassanien O; Shalaby L; Nagy M
    Per Med; 2022 Nov; 19(6):495-507. PubMed ID: 36239598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knowledge, attitude, practice and barriers towards pharmacovigilance and adverse drug reactions reporting among healthcare professionals in Turkey: a systematic review.
    Khan Z; Karatas Y; Martins MAP; Jamshed S; Rahman H
    Curr Med Res Opin; 2022 Jan; 38(1):145-154. PubMed ID: 34694167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knowledge of Adverse Drug Reaction Reporting Among Healthcare Professionals in Bhutan: A Cross-Sectional Survey.
    Dorji C; Tragulpiankit P; Riewpaiboon A; Tobgay T
    Drug Saf; 2016 Dec; 39(12):1239-1250. PubMed ID: 27743333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of a pharmacist-driven pharmacovigilance system in a secondary hospital in the Gauteng Province of South Africa.
    Terblanche A; Meyer JC; Godman B; Summers RS
    Hosp Pract (1995); 2018 Oct; 46(4):221-228. PubMed ID: 30092683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacists' experiences on adverse drug reaction: 10 years later.
    Karuppannan M; Mohamad Rizal NAN; Wong KT; Mohd Ali S; Ting KN; Boardman H
    Front Pharmacol; 2022; 13():932942. PubMed ID: 36249772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers and facilitators to pharmacovigilance activities in Pakistan: A healthcare professionals-based survey.
    Hussain R; Akram T; Hassali MA; Muneswarao J; Rehman AU; Hashmi F; Babar ZU
    PLoS One; 2022; 17(7):e0271587. PubMed ID: 35905133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Systematic Review of Healthcare Professionals' Knowledge, Attitudes, and Practices Regarding Adverse Drug Reaction Reporting in Ethiopia.
    Anbeo ZG; Abacıoğlu N
    Turk J Pharm Sci; 2023 Jul; 20(3):198-209. PubMed ID: 37417202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Awareness, Actions, and Predictors of Actions on Adverse Drug Reaction Reporting among Patients Attending a Referral Hospital in Southern Highland Tanzania.
    Sirili N; Kilonzi M; Mwakawanga DL; Mohamedi JA; Thobias JM; Clement A; Mwasomola D; Mushy SE
    Adv Pharmacol Pharm Sci; 2023; 2023():7761649. PubMed ID: 37200768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Awareness and Reporting of Antiretroviral Adverse Events Among Clients and Health-Care Providers at a Referral Hospital in Moshi, Northern Tanzania: A Cross-Sectional Study.
    Kiwanuka M; Muro FJ; Alloyce PJ; Muro EP
    East Afr Health Res J; 2019; 3(2):151-157. PubMed ID: 34308208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of Awareness of Pharmacovigilance among Young Health-care Professionals in India: An Issue Requiring Urgent Intervention.
    Singh J; Singh H; Rohilla R; Kumar R; Gautam CS
    Int J Appl Basic Med Res; 2018; 8(3):158-163. PubMed ID: 30123745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An observational study to compare the contents and quality of information furnished in CDSCO ADR reporting form, yellow card, medwatch and blue form by the healthcare professionals.
    Rehan HS; Chopra D; Holani SN; Mishra R
    Int J Risk Saf Med; 2014; 26(1):1-8. PubMed ID: 24796346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Awareness, knowledge, attitude and practice of adverse drug reaction reporting among health workers and patients in selected primary healthcare centres in Ibadan, southwestern Nigeria.
    Adisa R; Omitogun TI
    BMC Health Serv Res; 2019 Dec; 19(1):926. PubMed ID: 31796034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of an educational intervention on pharmacovigilance knowledge and attitudes among health professionals in a Nepal cancer hospital.
    Shrestha S; Sharma S; Bhasima R; Kunwor P; Adhikari B; Sapkota B
    BMC Med Educ; 2020 Jun; 20(1):179. PubMed ID: 32493307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medication safety knowledge, attitude, and practice among hospital pharmacists in tertiary care hospitals in Saudi Arabia: a multi-center study.
    Al-Mutairi A; AlFayyad I; Altannir Y; Al-Tannir M
    Arch Public Health; 2021 Jul; 79(1):130. PubMed ID: 34253257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.